Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Waking up to sleeping sickness.

August Stich1, Michael P Barrett, Sanjeev Krishna

  • 1Medical Mission Institute, Department of Tropical Medicine and Epidemic Control, Hermann-Schell-Str. 7, D-97074 Würzburg, Germany.

Trends in Parasitology
|May 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cell surface transporter mediates phenanthridine resistance in African trypanosomes.

npj antimicrobials and resistance·2026
Same author

Beyond resistance: Emerging methods to dissect drug responses in Leishmania.

PLoS pathogens·2026
Same author

Multi-drug tolerance in Leishmania persister-like cells.

Communications biology·2026
Same author

Rapid detection and quantification of glyphosate in water using a handheld portable biosensor.

Scientific reports·2026
Same author

Mechanisms of PfDNMT2 inhibition and PfATP6-mediated resistance to the antimalarial candidate SC83288 in Plasmodium falciparum.

Nature communications·2026
Same author

A rare complication in humans of a rare disease in Germany: a case of bilateral tubo-ovarian abscesses caused by Brucella melitensis.

Infection·2026
Same journal

Hidden diversity in Trichuris control.

Trends in parasitology·2026
Same journal

The second Cryptosporidium meeting: Edinburgh's parasite deep dive.

Trends in parasitology·2026
Same journal

Evolution of generalism under Muller's ratchet.

Trends in parasitology·2026
Same journal

Next generation in parasitology 2026: Connecting young parasitologists across Europe.

Trends in parasitology·2026
Same journal

Disrupted barriers, evolved risks: toward precision One Health in arthropod allergy.

Trends in parasitology·2026
Same journal

Unveiling malaria history using ancient genomes.

Trends in parasitology·2026
See all related articles

Human African trypanosomiasis is resurging in sub-Saharan Africa due to neglected research and control efforts. New initiatives offer hope but may be insufficient to reverse the deadly epidemic.

Area of Science:

  • Tropical medicine
  • Epidemiology
  • Infectious diseases

Background:

  • Human African trypanosomiasis (HAT), also known as sleeping sickness, is re-emerging in sub-Saharan Africa.
  • Decades of neglected clinical research, drug development, disease surveillance, and vector control have exacerbated the epidemic.
  • The resurgence poses a significant threat to public health in affected regions.

Purpose of the Study:

  • To highlight the critical re-emergence of human African trypanosomiasis.
  • To underscore the historical neglect of research and control initiatives for HAT.
  • To assess the potential impact of recent and ongoing control efforts.

Main Methods:

  • Review of recent trends in HAT epidemics.
  • Analysis of past and current research and control strategies.

Related Experiment Videos

  • Evaluation of new initiatives in drug development, surveillance, and vector control.

    • Main Results:

    • Significant re-emergence of HAT epidemics across sub-Saharan Africa.
    • Past neglect of research, drug development, surveillance, and vector control has contributed to the current crisis.
    • Emerging initiatives include free drug supply, new oral trypanocidal agents, advanced tsetse vector control, and pan-African coordination.

    Conclusions:

    • While recent efforts provide some hope, they may not be sufficient to reverse the resurgence of HAT.
    • Sustained and intensified research, drug development, and integrated control strategies are crucial.
    • Addressing the complex challenges of HAT requires a comprehensive and coordinated approach.